Arcturus Therapeutics Holdings Inc.

NASDAQ:ARCT

Biotechnology

Healthcare
$8.04 +1.97%

+$0.15 today

Market cap
$231.73M
Beta
2.35
P/E (TTM)
-2.7
EPS (TTM)
-$2.77
52W Low $5.85High $24.17

Volume 0.64M

Average 0.43M

Price history

Arcturus Therapeutics Holdings Inc. SEC filings

Start with how the market priced the stock, then connect its moves to the disclosures filed with the SEC.

Price history

Dividend-adjusted closing price

Period change

+33.11%

Period high

$16.93

Period low

$5.53

Latest

$8.04

SEC filings

What has the company disclosed?

Browse annual, quarterly, and current reports and other filings by form type.

SEC Filings

Recent regulatory filings

FormFiling DateAccepted
SC 13G/ANov 13, 2026Nov 13, 2026
10-QNov 5, 2026Nov 5, 2026
8-KNov 5, 2026Nov 5, 2026
SC 13G/AOct 29, 2026Oct 29, 2026
SC 13G/AOct 7, 2026Oct 7, 2026
8-KSep 23, 2026Sep 23, 2026
8-KAug 25, 2026Aug 25, 2026
10-QAug 6, 2026Aug 6, 2026
8-KAug 6, 2026Aug 6, 2026
8-KJul 2, 2026Jul 2, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026
4Jun 15, 2026Jun 15, 2026

Competitors

Who does Arcturus Therapeutics Holdings Inc. compete with?

Open similar companies to compare their filings and price history.

Questions

Filing questions

Common questions about ARCT's filings, answered from its disclosures.

What is the latest ARCT filing?

The latest filing shown is SC 13G/A dated Nov 13, 2026.

How many recent filings does ARCT have?

Intrinsic Alpha currently shows 20 recent filings for ARCT.